Protomer Technologies: Protomer Secures Additional Funding for Insulin Platform
Pasadena-based biopharmaceutical startup Protomer Technologies Inc. has closed a second investment raise for a drug platform that includes an insulin product that adjusts to varying glucose levels in patients.
Read full article »
Protomer is a California-based protein-engineering biotechnology company that develops and commercializes glucose insulins for the treatment of metabolic diseases.
Read more